Skip to content

Visualmed

Clinical trials summarized as Visual Abstracts

Menu
  • Submit Article
  • About
  • Private Policy
  • Visualmed App for iphone
  • Visualmed App for Android
  • List of Clinical Trials

Tag: heart failure

Posted onSeptember 27, 2020October 22, 2020Cardiovascular Disease

VERTIS CV Trial: Ertugliflozin Effect on CV Outcomes in Type 2 Diabetes

by admin

VERTIS CV Trial: The SGLT-2 inhibitors are the next generation drugs for type 2 diabetes as well as patients with heart failure. We have seen…

Read More
Posted onSeptember 11, 2020November 9, 2020Cardiovascular Disease

EMPEROR Reduced Trial: Empagliflozin in HFrEF

by admin

The SGLT-2 inhibitors were initially developed for diabetes but eventually noted to have significant effects on outcomes in patients with heart failure in addition to…

Read More
Posted onMay 2, 2020July 24, 2020Cardiovascular Disease

VICTORIA Trial: Vericiguat in Patients with HFrEF

by admin

The VICTORIA trial was a randomized controlled trial that tested the use of vericiguat in patients with heart failure with reduced ejection fraction. Vericiguat is…

Read More
Posted onMay 2, 2020July 24, 2020Cardiovascular Disease

VALIANT Trial: Valsartan, Captopril, or Both in MI complicated by HF

by admin
Read More
Posted onMay 2, 2020July 24, 2020Cardiovascular Disease

TRED HF Trial: Withdrawal of treatment for HF with recovered dilated cardiomyopathy

by admin
Read More
Posted onMay 2, 2020July 24, 2020Cardiovascular Disease

TOPCAT Trial: Spironolactone for Heart Failure with Preserved Ejection Fraction

by admin
Read More
Posted onMay 2, 2020July 24, 2020Cardiovascular Disease

SURVIVE Trial: Levosimendan vs dobutamine for patients with acute decompensated heart failure

by admin
Read More
Posted onMay 2, 2020December 20, 2020Nephrology

COAPT Trial: Transcatheter Mitral-Valve Repair in Patients with Heart Failure

by admin

COAPT Trial Summary Objective The goal of the COAPT trial was to evaluate the safety and effectiveness of transcatheter mitral-valve repair in patients with heart…

Read More
Posted onMay 2, 2020December 23, 2020Cardiovascular Disease

A-HeFT Trial: Isosorbide Dinitrate + Hydralazine in Blacks with Heart Failure

by admin
Read More

Subscribe via Email

Select list(s)*

 

Loading
Amphibious Theme by TemplatePocket ⋅ Powered by WordPress